Chlorhexidine Gluconate and Alcohol Hand Rubbing on Healthcare-associated Infection
a Comparison Between Effect of Chlorhexidine Gluconate and Alcohol Hand Rubbing on Healthcare-associated Infection
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Alexandria, Egypt, 0325
- Recruiting
- Marwa Mohamed Farag
-
Contact:
- Marwa M Farag
- Phone Number: 01143193333
- Email: d.marwa.farag@gmail.com
-
Contact:
- Hoda Ewiss, MD
- Email: h_soliman20110@alexmed.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Neonates <37 weeks gestational age admitted to NICU of Alexandria University Children's Hospitals
Exclusion Criteria:
Patients with any of the following will be excluded:
- Obvious major congenital abnormalities, immunodeficiency and inborn error of metabolism.
- Early onset sepsis (before the third day).
- Infants more than 72 hours of age at the time of randomization.
- Parental consent lacking/refusal.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Alcohol hand rub
Medical staff used chlorhexidine in hand rubs before contacting the neonates during their hospital stay.
|
Medical staff used alcohol in hand rubs before contacting the neonates during their hospital stay.
|
|
Active Comparator: chlorohexidine hand rub
Medical staff used alcohol in hand rubs before contacting the neonates during their hospital stay.
|
Medical staff used Chlorhexidine in hand rubs before contacting the neonates during their hospital stay.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
blood culture
Time Frame: first month of life
|
having blood culture from studied groups on day 7, 14, and 28 after birth.
|
first month of life
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 010820
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.